LIANY
Price
$0.27
Change
+$0.02 (+8.00%)
Updated
Dec 17 closing price
96 days until earnings call
TRML
Price
$19.98
Change
-$1.88 (-8.60%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

LIANY vs TRML

Header iconLIANY vs TRML Comparison
Open Charts LIANY vs TRMLBanner chart's image
LianBio
Price$0.27
Change+$0.02 (+8.00%)
Volume$247.3K
CapitalizationN/A
Tourmaline Bio
Price$19.98
Change-$1.88 (-8.60%)
Volume$1.13K
CapitalizationN/A
LIANY vs TRML Comparison Chart
Loading...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIANY vs. TRML commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a Sell and TRML is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (LIANY: $0.27 vs. TRML: $21.86)
Brand notoriety: LIANY and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 313% vs. TRML: 92%
Market capitalization -- LIANY: $28.72M vs. TRML: $560.55M
LIANY [@Biotechnology] is valued at $28.72M. TRML’s [@Biotechnology] market capitalization is $560.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than LIANY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIANY’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 3 bullish TA indicator(s).

  • LIANY’s TA Score: 4 bullish, 6 bearish.
  • TRML’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, LIANY is a better buy in the short-term than TRML.

Price Growth

LIANY (@Biotechnology) experienced а -2.46% price change this week, while TRML (@Biotechnology) price change was -12.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

LIANY is expected to report earnings on Mar 24, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($561M) has a higher market cap than LIANY($28.7M). LIANY YTD gains are higher at: 56.169 vs. TRML (-16.501).
LIANYTRMLLIANY / TRML
Capitalization28.7M561M5%
EBITDAN/A-78.78M-
Gain YTD56.169-16.501-340%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A282M-
Total DebtN/A290K-
TECHNICAL ANALYSIS
Technical Analysis
LIANYTRML
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 17 days ago
83%
Bullish Trend 20 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SEF35.490.24
+0.67%
ProShares Short Financials
ARKK62.980.04
+0.06%
ARK Innovation ETF
QVMS28.75N/A
N/A
Invesco S&P SmallCp 600 QVM Mlt-fctr ETF
PXI44.81-0.39
-0.86%
Invesco Dorsey Wright Energy MomentumETF
SMDV71.72-1.07
-1.47%
ProShares Russell 2000 Dividend Growers

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
+4.24%
SER - LIANY
69%
Closely correlated
+15.42%
GERN - LIANY
53%
Loosely correlated
+3.15%
TRML - LIANY
28%
Poorly correlated
-1.09%
OTLK - LIANY
23%
Poorly correlated
+0.70%
MTNB - LIANY
21%
Poorly correlated
+10.16%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-1.09%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
39%
Loosely correlated
-3.38%
BHVN - TRML
38%
Loosely correlated
-5.60%
SLRN - TRML
37%
Loosely correlated
+3.86%
IPSC - TRML
36%
Loosely correlated
N/A
More